Clinical Trial Update: Ulipristal Acetate for Use in Early Pregnancy Loss [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ulipristal acetate for medical management in early pregnancy loss has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anembryonic Pregnancy
• Missed Abortion
• Non-viable Pregnancy

Drugs mentioned

• Ulipristal acetate (ulipristal acetate)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Missed Abortion, Anembryonic Pregnancy | Phase 2 | Status: COMPLETED | Results posted: 2023-06-28